Evidence map›Paper›PMID 39634321›Full record

ArticleResearch and practice in thrombosis and haemostasis2024

Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with healthy volunteers.

Stefan F van Wonderen, Floor L F van Baarle, Anita M Tuip-de Boer, Chantal A Polet, Robin van Bruggen, Christie Vermeulen, Thomas R L Klei, Chi M Hau, Rienk Nieuwland, Cornelis van 't Veer and 5 more

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Stefan F van WonderenLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Floor L F van BaarleLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Anita M Tuip-de BoerLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Chantal A PoletLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Robin van BruggenDepartment of Blood Cell Research, Sanquin Blood Supply, Amsterdam, the Netherlands.
Christie VermeulenDepartment of Product and Process Development, Sanquin Blood Supply, Amsterdam, the Netherlands.
Thomas R L KleiDepartment of Product and Process Development, Sanquin Blood Supply, Amsterdam, the Netherlands.
Chi M HauLaboratory for Experimental Clinical Chemistry, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Rienk NieuwlandLaboratory for Experimental Clinical Chemistry, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Cornelis van 't VeerCenter of Experimental and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Anna L PetersLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Sanne de BruinLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Alexander P J VlaarLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Bart J BiemondDepartment of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Marcella C A MüllerDepartment of Intensive Care Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Platelet increment is reportedly lower for maximum stored platelet concentrates (PCs) and during pyrexia, and Objectives: The aim was to study differences in hemostatic function after transfusion of fresh or stored PCs in a human model of experimental endotoxemia. Methods: Thirty-six healthy male subjects received either 2 ng/kg lipopolysaccharide (LPS) or a control (physiological saline 0.9%) and were randomly assigned to subsequently receive an autologous transfusion of either fresh (2-days-old) or stored (7-days-old) platelets, or saline control. Extracellular vesicles (EVs) were determined using flow cytometry, thrombin-antithrombin complex (TATc) was assessed using enzyme-linked immunosorbent assay, and hemostatic function was assessed using rotational thromboelastometry (ROTEM). Results: LPS infusion caused a marked increase in TATc, EVs and fibrinolysis. Thromboelastometry data revealed that following infusion of LPS, subjects exhibited in general a hypocoagulable state compared with those not receiving LPS. Platelet transfusions led to a reduced clotting time and an augmentation in clot strength, indicated by maximum clot firmness, solely among subjects undergoing endotoxemia. There were no significant differences in TATc or amount of EVs release after transfusion of fresh or stored platelets. Conclusion: A significant increase in TATc and EVs as well as a difference in hemostatic function after endotoxemia were observed. During endotoxemia, platelet transfusion resulted in enhanced coagulation and hemostatic function; however, no substantial differences were observed between transfusion of fresh or stored PCs.

Indexed as

endotoxemiahemostasisplateletplatelet transfusionthromboelastography

Identifiers

PMID39634321
PMCPMC11616504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.